An investor forum to explore investment trends and opportunities in life sciences, with a focus on venture-stage growth and emerging public companies as well as those poised to join the growth “watch list” in 2016. Because our mission is to support industry-wide success, we strive to present a broad and unbiased view of investment opportunities.
The BIO Investor Forum delivers a rich program that features corporate presentations and panel debates on the sweet spots and growth challenges facing the industry. The BIO Investor Forum features:
- Public and venture-stage company presentations.
- Expert-led workshops on the latest market and investment opportunities with emphasis on drug and technology development.
- One-on-one investor meetings.
- Premier opportunity to network with industry executives and investors focused exclusively on life sciences.
Private equity and public investors, research analysts, and industry executives focused on investment and business development opportunities in the life sciences.
Why Investors Attend
- Hear from and meet with executives at the top life sciences growth companies.
- Evaluate fresh investment opportunities including compatible, complementary and competitive companies.
- Benefit from candid panel discussions with leading clinical experts and investigators with insights on pipeline research and clinical practice.
- Get a ‘big picture’ overview of the industry and the issues affecting product innovation, capitalization, and commercialization
Why Companies Attend
- Meet one-on-one with new and current investors, analysts, and partnering companies.
- Get the pulse on the latest life sciences investment trends from sophisticated investment and company executives.
- Showcase your company story in presentations to qualified investors.
- Network with peers, investors and potential partners.
What People are Saying About the BIO Investor Forum
"For us, the BIO Investor Forum is the bellwether of life science investing and business creation. As such, it's the "must go to" meeting on our calendar each year." - Graeme Martin, CEO, Takeda Ventures
“The BIO Investor Forum over the years has proved to be an excellent venue for investors to interact with a high quality group of emerging biotechnology companies and their senior management teams. The ongoing exposure to the investor community is invaluable to this group of companies as they execute their business strategies, achieve significant clinical catalysts and ultimately look to the capital markets to fund their continued advancement. Given my experience over the years, I have found this well-orchestrated conference to be a “must-attend” annual event.” - John Chambers, ROTH Capital Partners
BIO Investor Forum Statistics
- Over 900 attendees
- Over 1,700 partnering meetings scheduled, a 22% increase since 2014
- 175 private and public company presentations
- 295 partnering companies, an 18% increase over 2014
Attendees by Type